| Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype (NCT03718767) | National Cancer Institute (NCI) | 2019-03-27 |
| Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer (NCT03977272) | Zhejiang University | 2019-03-27 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) (NCT03823391) | AbbVie | 2019-03-27 |
| Adipose Tissue Injection in Perianal Fistulas in Crohn´s Disease (NCT03904212) | University of Aarhus | 2019-03-27 |
| Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899) (NCT03752723) | Genexine, Inc. | 2019-03-27 |
| Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment (NCT03531827) | National Cancer Institute (NCI) | 2019-03-26 |
| Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus (NCT03920267) | Bristol-Myers Squibb | 2019-03-26 |
| Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations (NCT03513562) | Ohio State University Comprehensive Cancer Center | 2019-03-26 |
| HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study (NCT03560258) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-03-26 |
| A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (NCT03861481) | UCB Biopharma S.P.R.L. | 2019-03-26 |
| A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy. (NCT03863483) | Xin-Hua Xu | 2019-03-26 |
| KN035 in Patients With Advanced Multiple Primary Tumors (NCT04182789) | RenJi Hospital | 2019-03-26 |
| Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy (NCT04561466) | Hôpital Necker-Enfants Malades | 2019-03-26 |
| A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy (NCT03695185) | AbbVie | 2019-03-26 |
| M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) (NCT03833661) | EMD Serono Research & Development Institute, Inc. | 2019-03-26 |
| Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors (NCT03585465) | Centre Oscar Lambret | 2019-03-26 |
| An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction (NCT03713424) | University of Missouri-Columbia | 2019-03-26 |
| Radiotherapy of Multiple Brain Metastases Using AGuIX® (NCT03818386) | University Hospital, Grenoble | 2019-03-26 |
| Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis (NCT04088721) | Advagene Biopharma Co. Ltd. | 2019-03-26 |
| Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care. (NCT03283488) | University of Sao Paulo | 2019-03-26 |
| A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients (NCT03917225) | Minoryx Therapeutics, S.L. | 2019-03-26 |
| Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck (NCT03818061) | Centre Leon Berard | 2019-03-26 |
| A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma (NCT03800706) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-03-25 |
| Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome (NCT03789175) | National Heart, Lung, and Blood Institute (NHLBI) | 2019-03-25 |
| Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer (NCT03772834) | M.D. Anderson Cancer Center | 2019-03-25 |
| Open-Label CA-008 (Vocacapsaicin) in Bunionectomy (NCT03885596) | Concentric Analgesics | 2019-03-25 |
| High Dose Albumin in Refractory Ascites (NCT05867602) | Baylor College of Medicine | 2019-03-25 |
| The Effects of Preoperatively Chewing Gum on Sore Throat After General Anaesthesia With a Laryngeal Mask (NCT03885752) | Fudan University | 2019-03-25 |
| Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy (NCT03813056) | Michael D. Straiko, MD | 2019-03-25 |
| Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy (NCT04233710) | University of Calgary | 2019-03-25 |
| FGFR Inhibitor in FGFR Dysregulated Cancer (NCT03827850) | Lung Cancer Group Cologne | 2019-03-25 |
| Saline Versus Albumin Fluid for Extracorporeal Removal With Slow Low Efficiency Dialysis Feasibility Study (NCT03665311) | Ottawa Hospital Research Institute | 2019-03-25 |
| ReShape Vest™ for the Treatment of Obesity (Europe) (NCT03918564) | ReShape Lifesciences | 2019-03-25 |
| Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (NCT03788291) | University of Rochester | 2019-03-25 |
| A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis (NCT03864627) | Lakefront Biotherapeutics NV | 2019-03-25 |
| Itacitinib for Low Risk GVHD (NCT03846479) | John Levine | 2019-03-25 |
| Topical Pentoxifylline Gel on Behcet's Disease Oral Ulcers (NCT03888846) | Ipekyolu Ilac Ltd. Sti | 2019-03-25 |
| NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer (NCT03832621) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-03-25 |
| A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission (NCT03850535) | Hoffmann-La Roche | 2019-03-25 |
| HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC (NCT03869034) | Sun Yat-sen University | 2019-03-25 |
| Testing Ramipril to Prevent Memory Loss in People With Glioblastoma (NCT03475186) | Wake Forest University Health Sciences | 2019-03-25 |
| Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma (NCT03857815) | Shanghai Zhongshan Hospital | 2019-03-25 |
| Acute Treatment Trial in Adult Subjects With Migraines (NCT03872453) | Pfizer | 2019-03-25 |
| Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome (NCT03790865) | Millendo Therapeutics SAS | 2019-03-25 |
| Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis (NCT03831776) | St. Olavs Hospital | 2019-03-25 |
| Nutritional Intervention With Table Olives in Healthy Volunteers (NCT03886597) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2019-03-25 |
| Evaluation of CN-105 in Subject With Acute Supratentorial Intracerebral Hemorrhage (NCT03711903) | National Neuroscience Institute | 2019-03-24 |
| Nab-PCE vs PC for MM After Failure of Anti-PD-1 (NCT03917069) | Peking University Cancer Hospital & Institute | 2019-03-23 |
| Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization (NCT03802461) | Susy Hota | 2019-03-22 |
| An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis (NCT03557281) | GlaxoSmithKline | 2019-03-22 |
| A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye (NCT04092907) | Harbour BioMed (Guangzhou) Co. Ltd. | 2019-03-22 |
| Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) (NCT03938246) | Sagimet Biosciences Inc. | 2019-03-22 |
| Utilization of Hepatitis C Positive Kidneys in Negative Recipients (NCT03801707) | Ohio State University | 2019-03-22 |
| Woodsmoke Particulate + Prednisone (NCT03861390) | University of North Carolina, Chapel Hill | 2019-03-22 |
| An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) (NCT03712787) | AbbVie | 2019-03-22 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure (NCT03860155) | RHEACELL GmbH & Co. KG | 2019-03-22 |
| Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation (NCT04018937) | Emory University | 2019-03-22 |
| A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia (NCT03874858) | Novartis Pharmaceuticals | 2019-03-22 |
| Synaptic Plasticity and Cognitive Function in RASopathies (NCT03504501) | Technical University of Munich | 2019-03-22 |
| Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) (NCT03834220) | Debiopharm International SA | 2019-03-22 |
| An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma (NCT03765229) | UNC Lineberger Comprehensive Cancer Center | 2019-03-22 |
| Apotransferrin in Patients With β-thalassemia (NCT03993613) | Prothya Biosolutions | 2019-03-21 |
| Investigation of the Efficacy and Safety of CHI-921 in Insomnia. (NCT03984604) | Canopy Growth Corporation | 2019-03-21 |
| X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases (NCT04415320) | Betta Pharmaceuticals Co., Ltd. | 2019-03-21 |
| Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736) (NCT03795207) | Institut Cancerologie de l'Ouest | 2019-03-21 |
| Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC (NCT04293679) | Sirnaomics | 2019-03-21 |
| A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension (NCT03897868) | Hanmi Pharmaceutical Company Limited | 2019-03-21 |
| Comparing NicoBloc to Nicotine Lozenges (NCT03720899) | University of Alabama at Birmingham | 2019-03-21 |
| Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection (NCT03806803) | University of Alberta | 2019-03-21 |
| The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation (NCT03621657) | University of Wisconsin, Madison | 2019-03-21 |
| Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata (NCT03811912) | Concert Pharmaceuticals | 2019-03-21 |
| Pilot rTMS for AUD+mTBI (NCT03995173) | VA Office of Research and Development | 2019-03-21 |
| Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma (NCT04031534) | Centre Henri Becquerel | 2019-03-21 |
| Mepo for Eosinophilic Esophagitis (EoE) Study (NCT03656380) | University of North Carolina, Chapel Hill | 2019-03-20 |
| Feasibility of the LUM Imaging System for Detection of Prostate Cancer (NCT03441464) | Lumicell, Inc. | 2019-03-20 |
| Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers (NCT03868423) | Sameek Roychowdhury | 2019-03-20 |
| A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies. (NCT04057118) | Oscotec Inc. | 2019-03-20 |
| Olaparib in Recurrent IDH-mutant Glioma (NCT03561870) | Hospices Civils de Lyon | 2019-03-20 |
| APX005M and Doxorubicin in Advanced Sarcoma (NCT03719430) | Alexander Z. Wei, MD | 2019-03-20 |
| ART Restorations With High-viscosity Glass-ionomer Cement Versus Hall Technique in Primary Molars (NCT05462808) | Esra Oz | 2019-03-20 |
| Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer (NCT04067830) | Roswell Park Cancer Institute | 2019-03-20 |
| Platelet Enriched Plasma for Treatment of Interstitial Cystitis (NCT04118946) | Mansoura University | 2019-03-20 |
| Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery (NCT03694002) | SWOG Cancer Research Network | 2019-03-20 |
| Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer (NCT03770689) | EMD Serono Research & Development Institute, Inc. | 2019-03-20 |
| Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer (NCT03802058) | Wuhan University | 2019-03-20 |
| A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia (NCT03692052) | Agios Pharmaceuticals, Inc. | 2019-03-20 |
| Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC (NCT03719300) | Anchiano Therapeutics Israel Ltd. | 2019-03-20 |
| A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) (NCT03657043) | Seagen Inc. | 2019-03-20 |
| NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment (NCT03482167) | University of Delaware | 2019-03-20 |
| Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation (NCT03805477) | University Hospital, Basel, Switzerland | 2019-03-20 |
| Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions (NCT04228653) | Renishaw | 2019-03-20 |
| The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma (NCT03800953) | National Taiwan University Hospital | 2019-03-20 |
| Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation (NCT03925350) | California Pacific Medical Center Research Institute | 2019-03-20 |
| Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan (NCT03844945) | Aerie Pharmaceuticals | 2019-03-19 |
| Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma (NCT03787602) | Kartos Therapeutics, Inc. | 2019-03-19 |
| A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors (NCT03760081) | Astellas Pharma Global Development, Inc. | 2019-03-19 |
| Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma (NCT04119674) | Zhejiang Cancer Hospital | 2019-03-19 |
| Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas (NCT03262116) | Massachusetts General Hospital | 2019-03-19 |
| Dosing of Methadone for Spine Surgery (NCT03605901) | University of Florida | 2019-03-19 |
| Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia (NCT03749226) | Hospital Universitari Joan XXIII de Tarragona. | 2019-03-19 |